Abstract:Objective: To analyze the occurrence and risk factors of residual pain in patients with osteoporotic thoracolumbar compression fractures after percutaneous vertebroplasty. Methods: A total of 120 patients with osteoporotic thoracolumbar compression fractures who were treated in our hospital from May 2013 to June 2021 after percutaneous vertebroplasty were included in the study. All patients were followed up for 6 months, and their clinical data were retrospectively collected. The patients were divided into the residual pain group (n=18) and the non-residual pain group (n=102) based on residual pain within 6 months after operation. The occurrence of residual pain in patients with osteoporotic thoracolumbar compression fractures after percutaneous vertebroplasty was analyzed, Univariate and multivariate Logistic regression analysis was used to analyze the risk factors of residual pain in patients with osteoporotic thoracolumbar compression fractures after percutaneous vertebroplasty. Results: 6 months after operation, 18 of 120 patients with osteoporotic thoracolumbar compression fractures had residual pain after percutaneous vertebroplasty, and the residual pain rate was 15.00%. The results of multivariate Logistic analysis showed that body mass indexes (BMI), adjacent vertebral fracture were risk factors for residual pain in patients with osteoporotic thoracolumbar compression fractures after percutaneous vertebroplasty (OR=1.683 and 10.700, P<0.05), bone cement diffuse to the preoperative fracture line, postoperative vertebral height recovery rate, postoperative Cobb angle improvement rate, bone mineral density T value were protective factors for residual pain in patients with osteoporotic thoracolumbar compression fractures after percutaneous vertebroplasty (OR=6.170, 5.797, 5.734, 9.959, P<0.05). Conclusion: Residual pain still exists in patients with osteoporotic thoracolumbar compression fractures after percutaneous vertebroplasty, and its occurrence was associated with many factors, clinically, patients could be given targeted treatment according to the above indicators, thereby reducing the risk of occurrence and improving the prognosis of patients.